122 related articles for article (PubMed ID: 15073447)
1. Acute neuromuscular failure related to long-term botulinum toxin therapy.
Coletti Moja M; Dimanico U; Mongini T; Cavaciocchi V; Gerbino Promis PC; Grasso E
Eur Neurol; 2004; 51(3):181-3. PubMed ID: 15073447
[No Abstract] [Full Text] [Related]
2. Pyridostigmine for the Reversal of Severe Adverse Reactions to Botulinum Toxin in Children.
Boerner RM; Young DL; Gnagi SH; White DR; Halstead LA
J Pediatr; 2018 Mar; 194():241-243. PubMed ID: 29275924
[TBL] [Abstract][Full Text] [Related]
3. Pyridostigmine for reversal of severe sequelae from botulinum toxin injection.
Young DL; Halstead LA
J Voice; 2014 Nov; 28(6):830-4. PubMed ID: 25008379
[TBL] [Abstract][Full Text] [Related]
4. Acute myocardial infarction after botulinum toxin injection.
Stähli BE; Altwegg L; Lüscher TF; Corti R
QJM; 2011 Jul; 104(7):615-6. PubMed ID: 20851822
[No Abstract] [Full Text] [Related]
5. Effects of botulinum toxin type a in the bladder wall of children with neurogenic bladder dysfunction: a comparison of histological features before and after injections.
Pascali MP; Mosiello G; Boldrini R; Salsano ML; Castelli E; De Gennaro M
J Urol; 2011 Jun; 185(6 Suppl):2552-7. PubMed ID: 21527192
[TBL] [Abstract][Full Text] [Related]
6. Efficacy and tolerability of botulinum toxin type A in patients with neurogenic detrusor overactivity and without concomitant anticholinergic therapy: comparison of two doses.
Grise P; Ruffion A; Denys P; Egon G; Chartier Kastler E
Eur Urol; 2010 Nov; 58(5):759-66. PubMed ID: 20674149
[TBL] [Abstract][Full Text] [Related]
7. Botulinum Toxin A in bruxers. One year experience.
Redaelli A
Saudi Med J; 2011 Feb; 32(2):156-8. PubMed ID: 21301762
[TBL] [Abstract][Full Text] [Related]
8. Botulinum toxin injections for pediatric patients with hereditary spastic paraparesis.
Geva-Dayan K; Domenievitz D; Zahalka R; Fattal-Valevski A
J Child Neurol; 2010 Aug; 25(8):969-75. PubMed ID: 20406997
[TBL] [Abstract][Full Text] [Related]
9. Botulinum toxin for urogenital conditions.
Eccleston KJ; Woolley PD
Int J STD AIDS; 2008 Dec; 19(12):797-9. PubMed ID: 19050206
[TBL] [Abstract][Full Text] [Related]
10. Prophylactic botulinum type A toxin complex (Dysport®) for migraine without aura.
Chankrachang S; Arayawichanont A; Poungvarin N; Nidhinandana S; Boonkongchuen P; Towanabut S; Sithinamsuwan P; Kongsaengdao S
Headache; 2011 Jan; 51(1):52-63. PubMed ID: 21083558
[TBL] [Abstract][Full Text] [Related]
11. Pilot study evaluating the safety of intradetrusor injections of botulinum toxin type A: investigation of generalized spread using single-fiber EMG.
Schnitzler A; Genet F; Durand MC; Roche N; Bensmail D; Chartier-Kastler E; Denys P
Neurourol Urodyn; 2011 Nov; 30(8):1533-7. PubMed ID: 21661038
[TBL] [Abstract][Full Text] [Related]
12. Botulinum toxin injection causing lateral rectus palsy.
Chen CS; Miller NR
Br J Ophthalmol; 2007 Jun; 91(6):843. PubMed ID: 17510486
[No Abstract] [Full Text] [Related]
13. Adverse events after botulinum A toxin injection for neurogenic voiding disorders.
De Laet K; Wyndaele JJ
Spinal Cord; 2005 Jul; 43(7):397-9. PubMed ID: 15741978
[TBL] [Abstract][Full Text] [Related]
14. Adverse events following botulinum toxin type A treatment in children with cerebral palsy.
Langdon K; Blair E; Davidson SA; Valentine J
Dev Med Child Neurol; 2010 Oct; 52(10):972-3; author reply 974. PubMed ID: 20561011
[No Abstract] [Full Text] [Related]
15. Safety and self-reported efficacy of botulinum toxin for adult spasticity in current clinical practice: a prospective observational study.
Muller F; Cugy E; Ducerf C; Delleci C; Guehl D; Joseph PA; Burbaud P; Dehail P
Clin Rehabil; 2012 Feb; 26(2):174-9. PubMed ID: 21937525
[TBL] [Abstract][Full Text] [Related]
16. Botulinum toxin A in the treatment of myofascial pain and dysfunction: the case against its use.
Laskin DM
J Oral Maxillofac Surg; 2012 May; 70(5):1240-2. PubMed ID: 22538023
[No Abstract] [Full Text] [Related]
17. Dysphagia as a complication of botulinum toxin injection to treat drooling.
Tighe D; Gok G; Moody A; Howlett D
Br J Oral Maxillofac Surg; 2014 Sep; 52(7):673; discussion 673-4. PubMed ID: 24845119
[No Abstract] [Full Text] [Related]
18. Writer's block: "texting" impairment as a complication of botulinum toxin type A therapy for palmar hyperhidrosis.
Lehman JS
Arch Dermatol; 2011 Jun; 147(6):752. PubMed ID: 21690551
[No Abstract] [Full Text] [Related]
19. The first documented case of true botulinum toxin granuloma.
Yun WJ; Kim JK; Kim BW; Lee SK; Kim YJ; Lee MW; Chang SE
J Cosmet Laser Ther; 2013 Dec; 15(6):345-7. PubMed ID: 23607737
[TBL] [Abstract][Full Text] [Related]
20. Systemic adverse events following botulinum toxin A therapy in children with cerebral palsy.
Naidu K; Smith K; Sheedy M; Adair B; Yu X; Graham HK
Dev Med Child Neurol; 2010 Feb; 52(2):139-44. PubMed ID: 20412252
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
